The Medical Minute



The Medical Minutes are also available on iTunes: Click here

Online Poll



New Link Between Exercise, PCa Found in Blood Vessels

New Link Between Exercise, PCa Found in Blood Vessels

Researchers found that PCa patients who walked at a faster pace were more likely to have healthier blood vessels.

Melatonin Levels Affect Prostate Cancer Risk

Melatonin Levels Affect Prostate Cancer Risk

Researchers conducted a study in Iceland that found an association between prostate cancer risk and quality of sleep.

Geographic Differences for Children on Donor Waitlist

Geographic Differences for Children on Donor Waitlist

A new study is suggesting there is substantial geographic variation in deceased donor kidney waiting times.

New Tool Predicts Prostate Cancer Overdiagnosis

New Tool Predicts Prostate Cancer Overdiagnosis

Researchers have developed a personalized tool that can predict the likelihood of prostate cancer overdiagnosis.

Novel Antibody Under Development for Type 1 Diabetes

Novel Antibody Under Development for Type 1 Diabetes

A new product known as BL-9020 is being developed by Israeli researchers.

Low-Fat Diet, Coffee Appear to Improve PCa Outcomes

Low-Fat Diet, Coffee Appear to Improve PCa Outcomes

This year, several studies have suggested some foods and beverages may be highly beneficial to men with prostate cancer.

Chemical in Dialyzers May Be Toxic to Immune Cells

Chemical in Dialyzers May Be Toxic to Immune Cells

Levels of bisphenol A in components of dialysis machines may be toxic to immune cells circulating in hemodialysis patients.

Investigational Drug May Boost Survival in Men with Metastatic PCa

Investigational Drug May Boost Survival in Men with Metastatic PCa

An investigational new agent called tasquinimod may help increase survival in men with metastatic prostate cancer.

Primary CKD Screening in the General Population Not Cost-Effective

Primary CKD Screening in the General Population Not Cost-Effective

A new systematic literature review has found that it may not be cost-effective to provide primary screening for CKD in the general population.

Experimental Agent Shows Promise for Peyronie's Disease

Experimental Agent Shows Promise for Peyronie's Disease

Phase 3 studies assessing XIAFLEX show this agent may significantly improve quality of life.

Sign Up for Free e-newsletters